Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients

BACKGROUND: Kidney allograft survival in human immunodeficiency virus (HIV)-positive patients is lower than that in the general population. Belatacept increases long-term patient and allograft survival rates when compared with calcineurin inhibitors (CNIs). Its use in HIV-positive recipients remains...

Descripción completa

Detalles Bibliográficos
Autores principales: El Sakhawi, Karim, Melica, Giovanna, Scemla, Anne, Bertrand, Dominique, Garrouste, Cyril, Malvezzi, Paolo, Rémy, Philippe, Moktefi, Anissa, Ingels, Alexandre, Champy, Cécile, Lelièvre, Jean-Daniel, Kheav, David, Morel, Antoine, Mokrani, David, Attias, Philippe, Grimbert, Philippe, Matignon, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323145/
https://www.ncbi.nlm.nih.gov/pubmed/34345414
http://dx.doi.org/10.1093/ckj/sfaa231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323145/
https://www.ncbi.nlm.nih.gov/pubmed/34345414
http://dx.doi.org/10.1093/ckj/sfaa231

Ejemplares similares